Targeted amplicon sequencing was performed in 39 patients (16 with Ph-like ALL and 23 with B other ALL).  RNA and cDNA were not available for further analysis, especially for JAK and ABL fusion. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.